Trial Profile
Trial to investigate the pharmacokinetics of controlled-release afamelanotide.
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 01 Aug 2011
Price :
$35
*
At a glance
- Drugs Afamelanotide (Primary)
- Indications Erythropoietic protoporphyria
- Focus Pharmacokinetics
- Sponsors Clinuvel Pharmaceuticals
- 12 Feb 2009 New trial record.